Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of CYFIP2 mRNA | increases expression | 19933214
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of CYFIP2 mRNA | affects expression | 21346803
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of CYFIP2 protein | affects expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of CYFIP2 mRNA | increases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CYFIP2 mRNA | increases expression | 20382639
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of CYFIP2 mRNA | increases expression | 18042831
|
D005472 |
Fluorouracil |
CYFIP2 protein affects the susceptibility to Fluorouracil | affects response to substance | 16217747
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of CYFIP2 mRNA | increases expression | 17039268 17982676
|
D005472 |
Fluorouracil |
TP53 protein affects the reaction [Fluorouracil results in increased expression of CYFIP2 mRNA] | affects reaction|increases expression | 15016801
|
D005472 |
Fluorouracil |
TP53 protein promotes the reaction [Fluorouracil results in increased expression of CYFIP2 mRNA] | increases expression|increases reaction | 17982676
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of CYFIP2 mRNA | affects cotreatment|increases expression | 17183730
|
C041786 |
palm oil |
palm oil results in increased expression of CYFIP2 mRNA | increases expression | 18042831
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of CYFIP2 mRNA | increases expression | 19482888
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CYFIP2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of CYFIP2 mRNA | affects binding|increases expression | 16214954
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CYFIP2 mRNA | increases expression | 19933214
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of CYFIP2 mRNA | affects cotreatment|increases expression | 17183730
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of CYFIP2 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
14.91 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
14.91 | 15322242 11752688 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
14.91 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.01 | 19490988 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.20 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.47 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.47 | 17638652 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.70 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
18.00 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
18.00 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
18.00 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.37 | 17688650 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.94 | 16511603 17963324 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.94 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.64 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.18 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.99 | 15238619 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 18775368 19232924 16609825 15238991 17157402 18558336 18396377 19460635 18940202 17507914 18177632 18985861 18316065 20603192 17688650 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.11 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.04 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.04 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.19 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.19 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.94 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.94 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
1.94 | 18608205 16557594 16110121 15136595 16595493 19217205 18357371 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.94 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.80 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.40 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.40 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.70 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
6.70 | 12619106 21507988 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
6.70 | 16332177 17088986 17045692 18930000 16799960 17971768 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
6.70 | 1701930 20007298 20935162 17173139 6705139 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.05 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.71 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
4.71 | 16757204 18986760 16280240 17066447 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.83 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.83 | 20889678 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.36 | 4080065 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.73 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.88 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 8697196 15668235 15340226 16354765 12621046 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.24 | 15001691 17016597 16510598 17287894 17725105 17169374 18772588 17018589 16340194 17172411 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.00 | 15148649 16331619 17454858 18802399 17094418 17695437 17255274 20501625 17401013 18383874 16303861 16524972 18509181 18288408 14970324 15289873 17594712 16391804 18949393 18448328 16282729 17016601 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.50 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.50 | 17688650 8888407 16575769 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.12 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.91 | 16733453 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.46 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.32 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.32 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.32 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.82 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.51 | 18367378 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
10.73 | 1851702 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
10.73 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.81 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.81 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 18230668 16714409 15322242 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
11.15 | 3659116 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
11.15 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
10.43 | 3922381 11558140 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
10.43 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
6.80 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
6.80 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
9.10 | 6401628 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
9.10 | 6254150 6426943 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
11.65 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
11.65 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
10.88 | 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
10.88 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.34 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
7.34 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
7.34 | 16481741 16337965 16785472 15173087 17638652 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
13.60 | 18296743 17967931 19004024 19551842 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.60 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
13.60 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.02 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.23 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
8.97 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.97 | 20067830 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.90 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.44 | 15102660 15162350 18337622 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.58 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.58 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.58 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
15.01 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
15.01 | 18467677 16221962 19176532 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
15.01 | 15340226 16120746 12621046 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.98 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 8697196 16959395 15340226 18606429 16354765 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.67 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.26 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.70 | 21332399 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.93 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.73 | 16612254 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
5.05 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.05 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.42 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.42 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.71 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
7.71 | 16985049 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.16 | 16294345 17596541 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
6.80 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.80 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.16 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.16 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.19 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
22.38 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
22.38 | 9163691 15890375 18177683 2125692 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
22.38 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
22.38 | 17045692 16603448 18383874 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
22.38 | 19812893 8742319 21047994 15975961 19482888 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
22.38 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
22.38 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.53 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
14.53 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
14.53 | 2563599 1399818 18308698 17172636 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.53 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.40 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
4.91 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.91 | 20464547 20064080 18569708 18520028 6695378 20869020 18816296 17053015 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
4.91 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.91 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.91 | 15086387 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.25 | 18765137 18803445 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
8.74 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
8.74 | 16757204 18986760 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.61 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.11 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.20 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.17 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.08 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.01 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.59 | 17484760 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.98 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.44 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
8.44 | 18600527 18239605 16928823 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.44 | 17405874 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.31 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.18 | 16359493 8888407 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.49 | 16436463 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.49 | 17217161 18457598 21332399 11836018 18674790 20132043 16723640 19632207 20518802 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.49 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.51 | 16049721 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.48 | 17016548 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.44 | 19003803 16929163 16500647 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
5.44 | 16965848 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.69 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.86 | 11118676 11896295 11222880 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.86 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.21 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.21 | 19082440 18626508 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
12.64 | 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
12.64 | 12752131 11422049 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.08 | 18286688 15538739 18722050 16160472 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.42 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.26 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.08 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
10.16 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
10.16 | 3137016 16876388 11442880 4039156 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
10.16 | 3137016 17978042 1511512 15475178 11044598 11738929 14763951 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.94 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.59 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.59 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.84 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.67 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.44 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.44 | 17498489 19084572 16424979 16951190 17522103 18396642 19015929 17172411 18567086 15786421 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
3.11 | 1399818 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.06 | 16280240 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.37 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.64 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.07 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.07 | 17053015 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.75 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.43 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
3.95 | 16803524 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.81 | 16723640 |